Literature DB >> 1161670

Bumetanide--acute and long term studies of a new high potency diuretic.

W R Murdoch, W H Auld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161670      PMCID: PMC2495680          DOI: 10.1136/pgmj.51.591.10

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide.

Authors:  D L Davies; A F Lant; N R Millard; A J Smith; J W Ward; G M Wilson
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

2.  Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.

Authors:  K H Olesen; B Sigurd; E Steiness; A Leth
Journal:  Acta Med Scand       Date:  1973 Jan-Feb

3.  The sites of action of bumetanide in man.

Authors:  E Bourke; M J Asbury; S O'Sullivan; P B Gatenby
Journal:  Eur J Pharmacol       Date:  1973-09       Impact factor: 4.432

4.  GLC determination and urinary recovery of bumetanide in healthy volunteers.

Authors:  P W Feit; K Roholt; H Sorensen
Journal:  J Pharm Sci       Date:  1973-03       Impact factor: 3.534

5.  Structure-activity studies on sulfamyl diuretics.

Authors:  P W Feit; O B Nielsen; H Bruun
Journal:  J Med Chem       Date:  1972-04       Impact factor: 7.446

6.  Aminobenzoic acid diuretics. 4. 4-Benzyl-5-sulfamylanthranilic acid derivatives and related 1,2-benzisothiazole 1,1-dioxides.

Authors:  P W Feit; O B Nielsen; N Rastrup-Andersen
Journal:  J Med Chem       Date:  1973-02       Impact factor: 7.446

7.  Bumetanide: potent new "loop" diuretic.

Authors:  M J Asbury; P B Gatenby; S O'Sullivan; E Bourke
Journal:  Br Med J       Date:  1972-01-22

8.  Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfamylbenzoic acid derivatives.

Authors:  P W Feit
Journal:  J Med Chem       Date:  1971-05       Impact factor: 7.446

  8 in total
  6 in total

1.  Pharmacokinetics of intravenously administered bumetanide in man.

Authors:  P J Pentikäinen; P J Neuvonen; M Kekki; A Penttilä
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

Review 2.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

3.  Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.

Authors:  R Lambe; O Kennedy; M Kenny; A Darragh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Bumetanide and frusemide: a comparison of dose-response curves in healthy men.

Authors:  L E Ramsay; G T McInnes; J Hettiarachchi; J Shelton; P Scott
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

Review 5.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

Review 6.  Off-Label Use of Bumetanide for Brain Disorders: An Overview.

Authors:  Shivani C Kharod; Seok Kyu Kang; Shilpa D Kadam
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.